Biomerica, Inc. (BMRA)
USD 0.51
(-4.89%)
USD 0.51
(-4.89%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 9.25 Million USD | -35.98% |
| 2023 | 14.45 Million USD | 27.08% |
| 2022 | 11.37 Million USD | -3.76% |
| 2021 | 11.81 Million USD | -31.52% |
| 2020 | 17.25 Million USD | 229.05% |
| 2019 | 5.24 Million USD | 0.44% |
| 2018 | 5.22 Million USD | 4.08% |
| 2017 | 5.01 Million USD | -12.37% |
| 2016 | 5.72 Million USD | -6.5% |
| 2015 | 6.12 Million USD | -5.35% |
| 2014 | 6.47 Million USD | 1.18% |
| 2013 | 6.39 Million USD | 14.79% |
| 2012 | 5.57 Million USD | 12.42% |
| 2011 | 4.95 Million USD | -1.19% |
| 2010 | 5.01 Million USD | -2.66% |
| 2009 | 5.15 Million USD | 0.87% |
| 2008 | 5.1 Million USD | 58.4% |
| 2007 | 3.22 Million USD | 32.79% |
| 2006 | 2.42 Million USD | -58.07% |
| 2005 | 5.79 Million USD | 4.0% |
| 2004 | 5.56 Million USD | 0.36% |
| 2003 | 5.54 Million USD | 5.14% |
| 2002 | 5.27 Million USD | -1.32% |
| 2001 | 5.34 Million USD | -20.61% |
| 2000 | 6.73 Million USD | -13.65% |
| 1999 | 7.8 Million USD | 4.0% |
| 1998 | 7.5 Million USD | 1.35% |
| 1997 | 7.4 Million USD | 21.31% |
| 1996 | 6.1 Million USD | 5.17% |
| 1995 | 5.8 Million USD | -7.94% |
| 1994 | 6.3 Million USD | 0.0% |
| 1993 | 6.3 Million USD | -1.56% |
| 1992 | 6.4 Million USD | -12.33% |
| 1991 | 7.3 Million USD | -18.89% |
| 1990 | 9 Million USD | 136.84% |
| 1989 | 3.8 Million USD | -20.83% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 9.25 Million USD | -35.98% |
| 2024 Q4 | 9.25 Million USD | -10.52% |
| 2024 Q3 | 10.34 Million USD | -12.59% |
| 2024 Q1 | 13.21 Million USD | -8.54% |
| 2024 Q2 | 11.83 Million USD | -10.5% |
| 2023 Q2 | 9.9 Million USD | -10.34% |
| 2023 Q1 | 11.05 Million USD | -2.85% |
| 2023 FY | 14.45 Million USD | 27.08% |
| 2023 Q4 | 14.45 Million USD | 76.05% |
| 2023 Q3 | 8.21 Million USD | -17.13% |
| 2022 Q1 | 11.51 Million USD | -2.56% |
| 2022 Q4 | 11.37 Million USD | -35.23% |
| 2022 FY | 11.37 Million USD | -3.76% |
| 2022 Q2 | 14.8 Million USD | 28.6% |
| 2022 Q3 | 17.56 Million USD | 18.58% |
| 2021 Q4 | 11.81 Million USD | -11.45% |
| 2021 FY | 11.81 Million USD | -31.52% |
| 2021 Q1 | 15.89 Million USD | -7.92% |
| 2021 Q2 | 14.47 Million USD | -8.9% |
| 2021 Q3 | 13.34 Million USD | -7.8% |
| 2020 FY | 17.25 Million USD | 229.05% |
| 2020 Q1 | 6.72 Million USD | 28.19% |
| 2020 Q2 | 7.03 Million USD | 4.68% |
| 2020 Q3 | 8.21 Million USD | 16.71% |
| 2020 Q4 | 17.25 Million USD | 110.1% |
| 2019 Q1 | 4.87 Million USD | -6.64% |
| 2019 Q3 | 5.06 Million USD | -6.65% |
| 2019 FY | 5.24 Million USD | 0.44% |
| 2019 Q4 | 5.24 Million USD | 3.5% |
| 2019 Q2 | 5.42 Million USD | 11.34% |
| 2018 Q1 | 4.91 Million USD | -2.08% |
| 2018 Q4 | 5.22 Million USD | 9.74% |
| 2018 Q3 | 4.75 Million USD | -1.49% |
| 2018 Q2 | 4.83 Million USD | -1.68% |
| 2018 FY | 5.22 Million USD | 4.08% |
| 2017 Q4 | 5.01 Million USD | -8.38% |
| 2017 FY | 5.01 Million USD | -12.37% |
| 2017 Q1 | 5.61 Million USD | -2.03% |
| 2017 Q2 | 5.58 Million USD | -0.44% |
| 2017 Q3 | 5.47 Million USD | -1.95% |
| 2016 Q4 | 5.72 Million USD | -2.54% |
| 2016 Q3 | 5.87 Million USD | -1.11% |
| 2016 Q2 | 5.94 Million USD | -2.19% |
| 2016 FY | 5.72 Million USD | -6.5% |
| 2016 Q1 | 6.07 Million USD | -0.81% |
| 2015 FY | 6.12 Million USD | -5.35% |
| 2015 Q2 | 5.92 Million USD | -1.97% |
| 2015 Q4 | 6.12 Million USD | 5.02% |
| 2015 Q3 | 5.83 Million USD | -1.62% |
| 2015 Q1 | 6.04 Million USD | -6.54% |
| 2014 FY | 6.47 Million USD | 1.18% |
| 2014 Q4 | 6.47 Million USD | 3.18% |
| 2014 Q2 | 5.82 Million USD | -6.09% |
| 2014 Q1 | 6.2 Million USD | -2.96% |
| 2014 Q3 | 6.27 Million USD | 7.62% |
| 2013 Q2 | 6.05 Million USD | 1.3% |
| 2013 Q1 | 5.98 Million USD | 7.35% |
| 2013 FY | 6.39 Million USD | 14.79% |
| 2013 Q4 | 6.39 Million USD | 4.65% |
| 2013 Q3 | 6.11 Million USD | 0.86% |
| 2012 Q3 | 5.54 Million USD | 9.25% |
| 2012 Q1 | 4.97 Million USD | 0.32% |
| 2012 FY | 5.57 Million USD | 12.42% |
| 2012 Q2 | 5.07 Million USD | 2.08% |
| 2012 Q4 | 5.57 Million USD | 0.48% |
| 2011 FY | 4.95 Million USD | -1.19% |
| 2011 Q1 | 4.87 Million USD | -2.83% |
| 2011 Q2 | 4.78 Million USD | -1.83% |
| 2011 Q3 | 4.85 Million USD | 1.54% |
| 2011 Q4 | 4.95 Million USD | 2.01% |
| 2010 Q2 | 4.91 Million USD | -4.9% |
| 2010 Q1 | 5.16 Million USD | 0.21% |
| 2010 FY | 5.01 Million USD | -2.66% |
| 2010 Q3 | 5.11 Million USD | 4.25% |
| 2010 Q4 | 5.01 Million USD | -2.02% |
| 2009 Q1 | 5.15 Million USD | 0.9% |
| 2009 Q4 | 5.15 Million USD | -2.3% |
| 2009 FY | 5.15 Million USD | 0.87% |
| 2009 Q2 | 5.04 Million USD | -2.19% |
| 2009 Q3 | 5.27 Million USD | 4.62% |
| 2008 Q2 | 4.07 Million USD | 2.92% |
| 2008 Q3 | 4.13 Million USD | 1.31% |
| 2008 Q4 | 5.1 Million USD | 23.62% |
| 2008 FY | 5.1 Million USD | 58.4% |
| 2008 Q1 | 3.96 Million USD | 22.89% |
| 2007 Q2 | 2.65 Million USD | 4.31% |
| 2007 Q4 | 3.22 Million USD | 14.88% |
| 2007 Q1 | 2.54 Million USD | 4.97% |
| 2007 FY | 3.22 Million USD | 32.79% |
| 2007 Q3 | 2.8 Million USD | 5.57% |
| 2006 Q4 | 2.42 Million USD | 3.5% |
| 2006 Q1 | 6.01 Million USD | 3.93% |
| 2006 Q2 | 6.68 Million USD | 11.03% |
| 2006 Q3 | 2.34 Million USD | -64.89% |
| 2006 FY | 2.42 Million USD | -58.07% |
| 2005 Q3 | 5.83 Million USD | 0.38% |
| 2005 FY | 5.79 Million USD | 4.0% |
| 2005 Q2 | 5.81 Million USD | 2.98% |
| 2005 Q1 | 5.64 Million USD | 1.46% |
| 2005 Q4 | 5.79 Million USD | -0.84% |
| 2004 Q3 | 5.54 Million USD | 5.46% |
| 2004 FY | 5.56 Million USD | 0.36% |
| 2004 Q2 | 5.25 Million USD | -2.36% |
| 2004 Q1 | 5.38 Million USD | -3.01% |
| 2004 Q4 | 5.56 Million USD | 0.49% |
| 2003 Q3 | 5.11 Million USD | 2.32% |
| 2003 Q1 | 4.91 Million USD | -6.88% |
| 2003 Q2 | 4.99 Million USD | 1.7% |
| 2003 Q4 | 5.54 Million USD | 8.5% |
| 2003 FY | 5.54 Million USD | 5.14% |
| 2002 Q1 | 5.42 Million USD | 1.5% |
| 2002 Q2 | 5.2 Million USD | -4.16% |
| 2002 Q3 | 5.36 Million USD | 3.06% |
| 2002 Q4 | 5.27 Million USD | -1.56% |
| 2002 FY | 5.27 Million USD | -1.32% |
| 2001 Q2 | 6.35 Million USD | -2.54% |
| 2001 Q4 | 5.34 Million USD | -12.37% |
| 2001 Q3 | 6.1 Million USD | -4.03% |
| 2001 FY | 5.34 Million USD | -20.61% |
| 2001 Q1 | 6.52 Million USD | -3.14% |
| 2000 FY | 6.73 Million USD | -13.65% |
| 2000 Q1 | 9.4 Million USD | 20.51% |
| 2000 Q2 | 8.8 Million USD | -6.38% |
| 2000 Q4 | 6.73 Million USD | -14.8% |
| 2000 Q3 | 7.9 Million USD | -10.17% |
| 1999 Q3 | 7.4 Million USD | -1.33% |
| 1999 Q4 | 7.8 Million USD | 5.41% |
| 1999 Q2 | 7.5 Million USD | -2.6% |
| 1999 Q1 | 7.7 Million USD | 2.67% |
| 1999 FY | 7.8 Million USD | 4.0% |
| 1998 Q4 | 7.5 Million USD | -1.32% |
| 1998 FY | 7.5 Million USD | 1.35% |
| 1998 Q1 | 7.5 Million USD | 1.35% |
| 1998 Q2 | 7.7 Million USD | 2.67% |
| 1998 Q3 | 7.6 Million USD | -1.3% |
| 1997 Q1 | 6.3 Million USD | 3.28% |
| 1997 FY | 7.4 Million USD | 21.31% |
| 1997 Q4 | 7.4 Million USD | -1.33% |
| 1997 Q3 | 7.5 Million USD | 19.05% |
| 1997 Q2 | 6.3 Million USD | 0.0% |
| 1996 Q1 | 5.7 Million USD | -1.72% |
| 1996 Q4 | 6.1 Million USD | 3.39% |
| 1996 Q3 | 5.9 Million USD | 3.51% |
| 1996 FY | 6.1 Million USD | 5.17% |
| 1996 Q2 | 5.7 Million USD | 0.0% |
| 1995 Q4 | 5.8 Million USD | 3.57% |
| 1995 FY | 5.8 Million USD | -7.94% |
| 1995 Q2 | 5.7 Million USD | -3.39% |
| 1995 Q3 | 5.6 Million USD | -1.75% |
| 1995 Q1 | 5.9 Million USD | -6.35% |
| 1994 Q1 | 5.9 Million USD | -6.35% |
| 1994 Q2 | 5.9 Million USD | 0.0% |
| 1994 FY | 6.3 Million USD | 0.0% |
| 1994 Q3 | 6.1 Million USD | 3.39% |
| 1994 Q4 | 6.3 Million USD | 3.28% |
| 1993 Q2 | 6.5 Million USD | 3.17% |
| 1993 Q4 | 6.3 Million USD | 0.0% |
| 1993 FY | 6.3 Million USD | -1.56% |
| 1993 Q1 | 6.3 Million USD | -1.56% |
| 1993 Q3 | 6.3 Million USD | -3.08% |
| 1992 Q3 | 6.7 Million USD | -4.29% |
| 1992 Q2 | 7 Million USD | -2.78% |
| 1992 Q4 | 6.4 Million USD | -4.48% |
| 1992 FY | 6.4 Million USD | -12.33% |
| 1992 Q1 | 7.2 Million USD | -1.37% |
| 1991 FY | 7.3 Million USD | -18.89% |
| 1991 Q4 | 7.3 Million USD | -7.59% |
| 1991 Q3 | 7.9 Million USD | -7.06% |
| 1991 Q2 | 8.5 Million USD | -2.3% |
| 1991 Q1 | 8.7 Million USD | -3.33% |
| 1990 Q1 | 4.1 Million USD | 7.89% |
| 1990 Q3 | 3.3 Million USD | 0.0% |
| 1990 Q4 | 9 Million USD | 172.73% |
| 1990 FY | 9 Million USD | 136.84% |
| 1989 Q4 | 3.8 Million USD | -13.64% |
| 1989 Q3 | 4.4 Million USD | 0.0% |
| 1989 FY | 3.8 Million USD | -20.83% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 70.497% |
| BrainsWay Ltd. | 62.97 Million USD | 85.305% |
| Cerus Corporation | 197.74 Million USD | 95.32% |
| Envoy Medical, Inc. | 7.64 Million USD | -21.126% |
| electroCore, Inc. | 16.38 Million USD | 43.528% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -20.307% |
| IceCure Medical Ltd | 16.41 Million USD | 43.608% |
| Inogen, Inc. | 326.19 Million USD | 97.163% |
| OrthoPediatrics Corp. | 449.58 Million USD | 97.942% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 66.065% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 44.182% |
| MaxCyte, Inc. | 268.27 Million USD | 96.551% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -14.285% |
| Nexalin Technology, Inc. | 3.63 Million USD | -154.797% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.0% |
| PAVmed Inc | 33.11 Million USD | 72.058% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 93.549% |
| RxSight, Inc. | 182.55 Million USD | 94.931% |
| Sight Sciences, Inc. | 166.65 Million USD | 94.447% |
| SI-BONE, Inc. | 230.42 Million USD | 95.984% |
| TELA Bio, Inc. | 78.04 Million USD | 88.143% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 96.326% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 13.756% |
| Acutus Medical, Inc. | 53.96 Million USD | 82.85% |
| Talis Biomedical Corporation | 98.34 Million USD | 90.59% |
| Spectral AI, Inc. | 10.69 Million USD | 13.449% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 95.768% |
| CVRx, Inc. | 115.22 Million USD | 91.969% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 84.225% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -197.055% |
| Bioventus Inc. | 810.91 Million USD | 98.859% |
| Venus Concept Inc. | 93.65 Million USD | 90.119% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 64.027% |
| LivaNova PLC | 2.42 Billion USD | 99.619% |
| 908 Devices Inc. | 202.98 Million USD | 95.441% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.851% |
| Nemaura Medical Inc. | 14.56 Million USD | 36.456% |
| NeuroPace, Inc. | 107.65 Million USD | 91.404% |
| LENSAR, Inc. | 69.58 Million USD | 86.701% |
| Apyx Medical Corporation | 79.24 Million USD | 88.322% |
| Cutera, Inc. | 346.29 Million USD | 97.328% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 77.975% |
| BioSig Technologies, Inc. | 1.79 Million USD | -414.683% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 96.581% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 78.308% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.755% |
| Axonics, Inc. | 719.92 Million USD | 98.715% |
| Outset Medical, Inc. | 313.8 Million USD | 97.051% |
| IRIDEX Corporation | 34.43 Million USD | 73.127% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 97.713% |
| IRadimed Corporation | 92.15 Million USD | 89.958% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -76.132% |
| INVO Bioscience, Inc. | 20.88 Million USD | 55.697% |
| Telesis Bio, Inc. | 70.41 Million USD | 86.857% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 93.995% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.259% |
| Quipt Home Medical Corp. | 247.4 Million USD | 96.26% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 0.602% |
| Pulmonx Corporation | 178.95 Million USD | 94.829% |
| Dynatronics Corporation | 25.94 Million USD | 64.326% |
| Modular Medical, Inc. | 13.8 Million USD | 32.976% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 13.732% |
| Semler Scientific, Inc. | 78.06 Million USD | 88.146% |
| InMode Ltd. | 863.28 Million USD | 98.928% |
| Bruker Corporation | 4.24 Billion USD | 99.782% |
| Cytosorbents Corporation | 53.26 Million USD | 82.625% |
| DexCom, Inc. | 6.26 Billion USD | 99.852% |
| Align Technology, Inc. | 6.08 Billion USD | 99.848% |
| Viveve Medical, Inc. | 25.91 Million USD | 64.288% |
| ZimVie Inc. | 1.2 Billion USD | 99.232% |
| Movano Inc. | 9.42 Million USD | 1.773% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 98.141% |
| Nexalin Technology, Inc. | 3.63 Million USD | -154.797% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 84.225% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.029% |
| Profound Medical Corp. | 43.68 Million USD | 78.817% |
| Insulet Corporation | 2.58 Billion USD | 99.642% |
| enVVeno Medical Corporation | 48.63 Million USD | 80.973% |
| Surmodics, Inc. | 185.73 Million USD | 95.018% |
| iCAD, Inc. | 41.41 Million USD | 77.657% |
| Nuwellis, Inc. | 9.77 Million USD | 5.281% |
| Biotricity, Inc. | 5.94 Million USD | -55.722% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 97.864% |
| Aethlon Medical, Inc. | 8.24 Million USD | -12.224% |
| InspireMD, Inc. | 47.64 Million USD | 80.576% |
| PAVmed Inc. | 33.11 Million USD | 72.058% |
| BIOLASE, Inc. | 35.1 Million USD | 73.636% |
| Beyond Air, Inc. | 56.96 Million USD | 83.754% |
| FONAR Corporation | 214.24 Million USD | 95.681% |
| AxoGen, Inc. | 196.82 Million USD | 95.298% |
| Vivani Medical, Inc. | 45.79 Million USD | 79.793% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 96.712% |
| Inari Medical, Inc. | 674.23 Million USD | 98.627% |
| UFP Technologies, Inc. | 404.13 Million USD | 97.71% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 60.451% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 2.621% |
| Tenon Medical, Inc. | 6.34 Million USD | -45.847% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 1.626% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 91.072% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.8% |
| Sintx Technologies, Inc. | 15.36 Million USD | 39.772% |
| NanoVibronix, Inc. | 6.67 Million USD | -38.657% |
| Quanterix Corporation | 425.01 Million USD | 97.823% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 0.602% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 82.776% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.47% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.689% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 85.356% |
| NeuroMetrix, Inc. | 21.42 Million USD | 56.806% |
| Hyperfine, Inc. | 94.19 Million USD | 90.176% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 96.555% |
| Bone Biologics Corporation | 3.73 Million USD | -147.581% |
| AVITA Medical, Inc. | 144.33 Million USD | 93.589% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -90.078% |
| Silk Road Medical, Inc | 265.3 Million USD | 96.512% |